DFV890
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for DFV890, covering 2024-05-03 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Efficacy, Safety, and Tolerability of DFV890 for Inflammatory Marker Reduction in Adult Participants With Coronary Heart Disease and Elevated hsCRP [Phase 2]